Home Health Care News April 26, 2023
Coming off an unfavorable final rule for Medicare Advantage (MA) plans, Humana Inc. (NYSE: HUM) is still riding high.
The company’s leaders explained the strategy behind recent success in MA, and future success in home health care, on an earnings call Wednesday.
During the call, Humana CEO Bruce Broussard applauded the Centers for Medicare & Medicaid Services (CMS) for adopting a three year phase-in in the risk model changes for the 2024 MA rate notice.
“It serves to mitigate the impact of unintended consequences to beneficiaries resulting from these changes,” he said.
Looking ahead, Humana has a rosier MA outlook, believing it will remain a “compelling” value proposition for seniors.
“We believe the industry will continue to see strong growth,”...
Today's Sponsors
Today's Sponsor